Annual Report 2013
Stockholm, Sweden — Medivir AB (OMX: MVIR) today announces that the Annual Report for 2013 now is available at the company’s website: www.medivir.com. Annual Report 2013 http://www.medivir.se/v5/images/pdf/2014/Medivir_2013_ENG.pdf “2013 was, without doubt, one of the most eventful years in Medivir’s 25-year history! The biggest single event during the year was the marketing approval of simeprevir – a pharmaceutical for the treatment of patients with chronic hepatitis C that we have helped develop. The approval has allowed the launch of simeprevir in Japan, Canada and the